Research Papers

25 of 264 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Efficacy of High-Flow Nasal Cannula versus Conventional Oxygen Therapy in Obese Patients during the Perioperative Perio…
Zhou R; Wang HT; Gu W.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System.
Ketabchi F; Jamzad S.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
Evaluating the Factors Affecting COVID-19 Patients' Mortality in Arak in 2020.
Mazaherpour H; Soofian M; Farahani E; Saebbian A; Etebari M; Mazaherpour S; Ashrafian F; Ramezani A.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Guidance for Administering Biologics for Severe Asthma and Allergic Conditions.
Dorscheid DR; Lee JK; Ramesh W; Greenwald M; Del Carpio J.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Value of Adenosine Deaminase 2 in the Detection of Tuberculous Pleural Effusion: A Meta-Analysis and Systematic Rev…
Zeng T; Ling B; Hu X; Wang S; Qiao W; Gao L; Shen Y; Li D.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Noninvasive Ventilation in Treatment of Respiratory Failure-Related COVID-19 Infection: Review of the Literature.
Mina B; Newton A; Hadda V.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma.
Tang H; Qiao C; Wang Y; Bai C.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Rem…
Yan F; Hu X; He L; Jiao K; Hao Y; Wang J.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic O…
Gong Y; Lin C; Jin Y; Chen R.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Role of CD40, CD86, and Glutathione S-Transferase Omega 1 in the Pathogenesis of Chronic Obstructive Pulmonary Dise…
Sun D; Lin R; Ouyang Y.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Inspiratory Muscle Rehabilitation Training in Pediatrics: What Is the Evidence?
Bhammar DM; Jones HN; Lang JE.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Polygonatum Polysaccharide Regulates Macrophage Polarization and Improves LPS-Induced Acute Lung Injury through TLR4-MA…
Zhou W; Hong J; Liu T; Li M; Jin H; Wang X.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Neutrophil-to-Lymphocyte Ratio is Associated with the Requirement and the Duration of Invasive Mechanical Ventilati…
Yang L; Gao C; He Y; Wang X; Yang L; Guo S; Chen J; He S; Sun Y; Gao Y; Guo Q.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis.
Hu M; Zhang L; Cao J; Jiang Y; Liu G.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Intensive Intervention Improves Outcomes for Chronic Obstructive Pulmonary Disease Patients: A Medical Consortium-Based…
Zhao S; Zheng L; Zhu M; Shui Y; Bao X; Zhao J.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Assessing the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Stage I Non-Small-Cell Lung Cancer with Complet…
Liu W; Zhang T; Li L; Zou J; Xu C.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
MicroRNA-877-5p Inhibits Cell Progression by Targeting FOXM1 in Lung Cancer.
Liu Z; Wang X; Cao L; Yin X; Zhang Q; Zhang Q; Wang L.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from M…
Liu C; Ran R; Li X; Liu G; Xie X; Li J.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis.
Sunaga N; Koga Y; Hachisu Y; Yamaguchi K; Aikawa M; Kasahara N; Miura Y; Tsurumaki H; Yatomi M; Sakurai R; Maeno T; Hisada T.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
Carboxyhemoglobin Does Not Predict the Need of Mechanical Ventilation and Prognosis during COPD Exacerbation.
Izhakian S; Harper E; Gorelik O; Frajman A; Mekiten O; Bar-Chaim A; Kramer MR.
Can Respir J (Unknown)
Published: 2022
2/6 Transparent
Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine aga…
Liu H; Li Y; Zhang X; Shi M; Li D; Wang Y.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pulmonary Manifestations of Primary Humoral Deficiencies.
Casal A; Riveiro V; Suárez-Antelo J; Ferreiro L; Rodríguez-Núñez N; Lama A; Toubes ME; Valdés L.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneum…
Mou S; Zhang W; Deng Y; Tang Z; Jiang D.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis.
Arai T; Hirose M; Hamano Y; Kagawa T; Murakami A; Kida H; Kumanogoh A; Inoue Y.
Can Respir J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared